Drugs

Double-Boosted Protease Inhibitor Antiretroviral Regimens: What Role?
pp. 2257-2267(11)
Authors: Ribera, Esteban; Curran, Adrian

Upcoming Agents for the Treatment of Schizophrenia: Mechanism of Action, Efficacy and Tolerability
pp. 2269-2292(24)
Authors: Bishara, Delia; Taylor, David

Topical Treatments for Scalp Psoriasis
pp. 2293-2302(10)
Authors: Warren, Richard B.; Brown, Benjamin C.; Griffiths, Christopher E.M.

Variceal Bleeding: Pharmacological Treatment and Prophylactic Strategies
pp. 2303-2324(22)
Authors: Villanueva, Cándid; Balanzó, Joaquim

Antithrombotic Therapies in Primary Angioplasty: Rationale, Results and Future Directions
pp. 2325-2344(20)
Authors: Giuseppe De Luca,; Marino, Paolo

Bivalirudin: In Patients with Acute Coronary Syndromes Planned for Urgent or Early Intervention
pp. 2345-2356(12)
Authors: Deeks, Emma D.; Curran, Monique P.

Etravirine
pp. 2357-2372(16)
Authors: Deeks, Emma D.; Keating, Gillian M.

Niacin Extended-Release/Simvastatin
pp. 2373-2386(14)
Authors: Sanford, Mark; Curran, Monique P.

Vildagliptin: A Review of its Use in the Management of Type 2 Diabetes Mellitus
pp. 2387-2409(23)
Authors: Croxtall, Jamie D.; Keam, Susan J.